BAP-65 Score for Acute Exacerbation of COPD
BUN, altered mental status, pulse > 109 and age > 65 (BAP-65) classify patients admitted with an exacerbation of COPD into five classes predicting in-hospital mortality and the need for mechanical ventilation.
Score interpretation
No risk factor and age ≤ 65 — in-hospital mortality 0.3% (Tabak 2009).
→ Standard exacerbation care; consider early discharge if otherwise appropriate.
No risk factor and age > 65.
→ Standard exacerbation care.
One risk factor.
→ Inpatient care with close monitoring; blood gas, and NIV if there is hypercapnic acidosis.
High risk of in-hospital death and of needing mechanical ventilation (rising with each class).
→ HDU / ICU review; early NIV or ventilation decisions; discuss ceilings of care.
All three risk factors — in-hospital mortality 13–15% (Tabak 2009); mechanical ventilation in about half (Shorr 2011).
→ HDU / ICU review; early NIV or ventilation decisions; discuss ceilings of care.
Interpretation bands for the BAP-65. Apply clinical judgement and local guidance.
References
- Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–1602.
- Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–1183.
Related
Curated clinical cross-links plus same-class fallbacks.
- Azithromycin (COPD Exacerbation Prophylaxis) · Macrolide antibiotic (anti-inflammatory / prophylactic)
- Doxycycline (COPD Exacerbation / CAP) · Oral tetracycline antibiotic
- Co-amoxiclav 625mg (COPD Exacerbation / CAP) · Beta-lactam / Beta-lactamase inhibitor combination antibiotic
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Milrinone · Inodilator / Acute Heart Failure
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.